News › Industry News, News

Revance Announces U.S. Distribution Deal for Dermal Fillers from Teoxane SA

January 13, 2020

Revance Therapeutics, Inc., a biotechnology company searching for new innovations in neuromodulators for aesthetic and therapeutic indications, has announced the signing of a U.S. distribution agreement with Teoxane SA, making Revance the exclusive commercialization partner of the Swiss company’s Resilient Hyaluronic Acid (RHA) technology.
Read more from Revance >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • 10 Marketing Truths Every Aesthetic Practice Needs to Hear Right Now
    • AI, FDA, PDGF: The Talk of MSS
    • Radiologists Warn that Décolletage Filler May Interfere with Breast Cancer Screening
    • The Beauty Health Company (SKIN) Rebrands to SkinHealth Systems
    • Amazon Launches GLP-1 Weight Loss Program with One Medical